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Many studies have shown that alcohol consumption is associated 
with alteration in immune responses and increased incidence of 
infection in the host. Tumor necrosis factor (TNF) is a potent soluble 
mediator of immunoregulation and inflammation, and plays a very 
important role in host's defenses against infection and tumor. We 
propose that one of the mechanisms of alcohol-mediated immuno- 
suppression may be due to a defect in the synthesis and release of 
the TNF. To determine this, we studied the direct effect of alcohol 
on lipopolysaccharide (LPS)-induced TNF production by whole blood 
and total mononuclear cell from normal subjects. Aliquots of blood 
samples (1 ml) or ficoll-hypaque separated total mononuclear cells 
(1 x 106/ml) were cultured with different concentrations of either 
ethanol or acetaldehyde in the presence or absence of LPS for 4 hr 
at 37OC. Plasma samples and culture supernatants were assayed 
for TNF levels in a bioassay using a TNF-sensitive WEHl 164 sub- 
clone 13 cell line. LPS at 10 ag/ml produced a maximal level of TNF 
compared with lower (1 ag/ml) or higher concentration (50 pglrnl) of 
LPS. Kinetics studies showed that an incubation time of 4 hr with 
LPS produced a maximum level of TNF production by blood. Alcohol, 
as low as 0.1% concentration, produced significant suppression of 
LPS-inducted TNF production by whole blood, whereas alcohol at 
0.2 and 0.3% concentrations were required to produce a significant 
suppression of TNF production by separated mononuclear cells. 
Anti-TNF-a antibodies significantly neutralized the LPS-induced TNF 
that suggests that blood monocytes may be the primary source of 
TNF production. Further, significant correlation between TNF produc- 
tion and monocyte numbers was observed. Acetaldehyde one of the 
primary metabolites of alcohol, did not suppress the LPS-induced 
TNF production by whole blood. These studies suggest that alcohol- 
induced inhibition of TNF may be one of the mechanisms for immu- 
nosuppression in alcoholic patients. 
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HE BODY'S ability to mount an antigen-specific re- T sponse is directly dependent on the production of 
multiple immunoregulatory proteins, cytokines. Tumor 
necrosis factor (TNF) is an important cytokine that is 
known to be involved in defense mechanisms against 
tumor and infectious and inflammatory diseases. Pre- 
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vious studies showed that TNF modulates the functions 
of polymorphonuclear ne~trophils,~ T-~ells,'.~ B-cells,'~ lo 
monocyte/macrophages," natural killer (NK),12 and lym- 
phokine-activated killer (LAK) cells.I3 TNF also interacts 
with other cytokines, particularly interferon-y , granulo- 
cyte-macrophage colony-stimulating factor, and interleu- 
kin (1L)-1, IL-2, and IL-4.I4-I7 Thus, TNF plays an im- 
portant role in the host's defense mechanisms. Previous 
studies have shown that chronic alcohol consumption is 
associated with dysfunctions of immune ~ y s t e m . ' ~ - ~ ~  We 
have earlier reported that the lymphocytes from nonalco- 
holic healthy donors precultured in vitro with different 
concentrations of alcohol manifested decreased level of 
NK and antibody-dependent cellular cytotoxic (ADCC), 
and LAK cell a~tivities.~' We have demonstrated that 
alcohol has a selective inhibitory effect on NK activity of 
lymphocytes from acquired immunodeficiency syndrome 
(AIDS) patients.36 Recent studies showed that acute alco- 
hol intoxication in rats markedly suppressed both serum 
and lung TNF, elicited in response to lipopolysaccharide 
(LPS)37 and intratracheal challenge with Staphylococcus 
aureus or Klebsiella These studies suggest 
that altered TNF release may have a role in the reduced 
immune response to infections in alcoholics. Although a 
number of in vitro and in vivo studies reported that 
alcohol modulates immune responses, the mechanisms by 
which alcohol alters these functions remains unclear. The 
present study was undertaken to investigate the direct 
effect of alcohol on TNF production by whole blood cells 
and separated total mononuclear cells in response to LPS 
in vitro. 
MATERIALS AND METHODS 
Blood Donors 
Blood donors were apprised of this study, and consents were obtained 
consistent with the policies of the appropriate institutions and the Na- 
tional Institutes of Health. Peripheral blood from a total of 36 healthy, 
human immunodeficiency virus (HIV) seronegative, nonalcoholic indi- 
viduals was drawn into a syringe containing heparin (20 units/ml). 
Subjects were free of medical or psychiatric illness and were not taking 
medications known to affect immune functions, including nonsteroidal 
antiinflammatory agents and substances of abuse. The age of the subjects 
ranged from 20 to 40 years. For each set of experiments, different blood 
donors were used, and no blood samples/blood donors were used inter- 
changeably. For each blood sample, a white blood cell count was obtained 
using a coulter counter (Coulter Electronics, Hialeach, FL). A blood 
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smear was also made and stained with Diff-Quik (Scientific Products, 
McGaw Park, IL) for a differential count. 
Experimental Design 
Total mononuclear cells were separated by ficoll-hypaque centrifuga- 
tion, and the cells were washed three times in Ca2+-Mg2+ free Hank's 
balanced salt solution. In experiments using whole blood samples, 1 ml 
of blood samples was aliquoted rapidly into sterile eppendorf tubes. In 
experiments using separated mononuclear cells, one million cells were 
cultured in complete medium containing 5% fetal bovine serum (FBS) 
(GIBCO), 300 pg/ml of fresh flutamine, and 80 pg gentamicin/ml 
(complete medium). Triplicates of blood samples and mononuclear 
preparations received ethanol (EtOH) at 0.1,0.2, and 0.3% final concen- 
trations and acetaldehyde at 0.001, 0.002, and 0.003% final concentra- 
tions. Triplicates of cultures also received these concentrations of EtOH 
and acetaldehyde separately plus LPS (Escherichiu coli no. G2630 Sigma 
Chemical Co., St. Louis, MO) at 1,5, 10, and 50 pg/ml final concentra- 
tions. As controls, triplicate blood samples and mononuclear cells cul- 
tures also received LPS or media alone. These control and treated cultures 
were incubated at 37'C for 2-24 hr in 5% C02 and 95% air incubator. 
At 2-, 4, 8-, and 24-hr intervals, treated and control samples were 
centrifuged at 900 X g for 10 min at 4"C, and the plasma and culture 
supernatants were separated, diluted 1 : 1 with RPMI 1640 media supple- 
mented with 1 % FBS, and stored at -20°C until assayed for TNF. The 
viability of leukocytes was examined at different periods of culture by 
trypan blue dye exclusion assay. The viability of alcohol-treated cultures 
was not affected and was found to be similar to that of control cultures. 
TNF Assay 
The TNF activities of the treated and control blood plasma fluids/ 
culture supernatants were determined by a cytotoxicity assay using TNF- 
sensitive WEHI 164 subclone 13 cell line (the generous gift of Dr. Daniel 
G. Remik, Department of Pathology, University of Michigan, Ann 
Arbor, MI). The method of measuring TNF was described or detailed 
earlier'9 and was standardized in our laboratory using human recombi- 
nant TNF (rTNF). The WEHI cell line is very sensitive to the cytotoxic 
effect of TNF and can detect as low as 2 pg/ml of TNF. Briefly, plasma/ 
culture supernatants were serially diluted with RPMI 1640 + 1 % FBS 
media and were added at 100 p1 quantities directly into the 96 well plates 
(Costar, Cambridge, MA). WEHI 164 cells resuspended at a concentra- 
tion of 5 x lo5 cells/ml in RPMI 1649 media containing 10% FBS and 
300 pg/ml of fresh glutamine + 0.5 pg/ml of actinomycin D (Calbi- 
ochem, Boehring Diagnostic, Lalolla CA) was added to each well in 100 
pl aliquots. As a standard, human rTNF (Peprotech, Rocky Hill, NJ) at 
different dilutions was included in the assay. The plates were incubated 
at 37'C for 20 hr, after which 20 p1 of 3-[4,5-dimethylthiazol-2-y1]2,5 
diphenyltetrazolium bromide (Sigma, 5 mg/ml) was added to each well 
and further incubated for 4 hr at 37°C. One hundred and fifty pl of 
supernatant was removed from each well and 100 pl of isopropanol:0.04 
N HCI was added to develop the dark blue crystals. The plates were 
covered with aluminum foil and allowed to remain at room temperature 
overnight to dissolve the crystals. Then the plates were read at 550 nm 
in an ELISA reader. The amount of TNF in the test supernatants was 
calculated on the basis of the standard curve that was obtained using the 
rTNF used as a standard in the same assay. 
In TNF neutralization assay, antihuman TNF-a and -B antibodies 
(rabbit polyclonal antisera, Sigma) were used at a concentration of 190 
dilution to give maximum inhibitory effect as determined by previous 
experiments. In brief, the test samples containing TNF were incubated 
for 1 hr at 37'C with anti-TNF sera and were then used in TNF assay 
using WEHI cell line as described. 
To investigate the possibility that metabolites of EtOH may alter the 
production of TNF, we studied one of the primary metabolites of EtOH, 
acetaldehyde on LPS-induced TNF production by whole blood. The 
final concentrations of acetaldehyde used were 0.001,0.002, and 0.003%. 
The choices of these concentrations were based on previously published 
reports of acetaldehyde concentration as determined in V ~ V O . ~ ~ ~ '  
Data Analysis 
Data were analyzed using repeated measures analyses of variance 
(ANOVA) (samples x doses) and Pearson correlation. The dose-response 
relationship of TNF production to alcohol or acetaldehyde was tested 
using a single linear contrast effect in the ANOVAs. A Pearson correlation 
was calculated to show the association of the number of monocytes to 
TNF production in the untreated condition. 
RESULTS 
Data presented in Fig. 1 show the kinetics of LPS- 
induced TNF in the plasma samples harvested at 2, 4, 8, 
and 24 hr after incubation of whole blood with LPS. 
Plasma samples from blood incubated with LPS for 2 hr 
contained 86 ng/ml of TNF. The maximum level of TNF 
was produced at 4 hr, the values of TNF being 175 ng/ 
ml. The TNF production was found to be lowered at 8 
and 24 hr, the values being 140 and 103 ng/ml, respec- 
tively. Based on this finding, further experiments were 
performed using 4-hr incubation periods of blood with 
LPS. 
Data presented in Fig. 2 show a dose-response effect of 
LPS on TNF production by normal blood. LPS at 1, 10, 
and 50 pg/ml produced 86, 189, and 160 ng TNF/ml of 
plasma, respectively. Because LPS at 10 pg/ml concentra- 
tion consistently produced maximal level of TNF in our 
hand (1 89 ng/ml), that concentration was used in our 
subsequent experiments. Data presented in Fig. 3 show a 
significant correlation between the number of monocytes 
and TNF production in the blood samples as calculated 
by the Pearson correlation coefficient. TNF productions 
was highly correlated with the number of monocytes ( r  = 
0.86, p < 0.0001). Data presented in Table 1 show the 
number of monocytes and the levels of TNF produced by 
whole blood in response to LPS in the presence and 
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Fig. 1. Kinetics of TNF release in LPS-stimulated human whole blood. Aliquots 
of whole blood samples (1 ml) were cultured with 10 pg/ml of LPS for 2 ,4,  8, and 
24 hr at 37OC. Plasma samples were assayed for TNF levels in a bioassay using a 
TNF-sensitive WEHI 164 subclone 13 cell line. A total of five separate experiments 
using five different blood samples were studied. Values are expressed as mean f 
SD. Mean monocyte count in these Mood samples was 641 f 108 (so)/ml of blood. 
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Fig. 2. Dose-response effect of LPS on TNF production by normal whole blood. 
Aliquots of a 1 ml blood sample were incubated with different concentrations of 
LPS for 4 hr at 37OC, and the plasma samples were quantitated for TNF using 
WEHl cell assay. Data represent mean k SO of five separate experiments using 
five different donors performed in triplicate. TNF levels in the plasma of blood 
cultured without LPS produced a negligible level of TNF. Mean monocyte count in 
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Fig. 3. Correlation between TNF production and number of monocytes. Number 
of monocytes and LPS-induced TNF production by 15 samples presented in Table 
1 have been calculated by the Pearson correlation coefficient evaluation. For 
descriptions on culture conditions, see table 1 footnotes. 
suppression of LPS-induced TNF production. TNF pro- 
duction was affected by alcohol concentration [F(3,42) = 
160.72, p < 0.00011; the linear component of this dose 
effect accounted for most of the variance [ F( 1,42) = 4 19.8, 
p < 0.000 I], indicating a strong dose-response relation- 
ship. Data presented in Table 2 show the levels of TNF 
produced by ficoll-hypaque separated total mononuclear 
cells in response to LPS in the presence and absence of 
different concentrations of EtOH. Total mononuclear cells 
cultured with LPS in the presence of 0.1, 0.2, and 0.3% 
EtOH differed in TNF production [F(3,9) = 26.1 1, p < 
0.000 11, and EtOH produced a dose-dependent suppres- 
sion of TNF production [linear contrast F( 1,9) = 75.24, p 
< 0.0001]. These data demonstrate that alcohol at intox- 
icating levels in vivo can significantly suppress TNF pro- 
duction. 
To examine the isotype of TNF produced in response 
to LPS, neutralization assay using anti-TNF-a and -/3 
antisera was performed. Data presented in Table 3 showed 
that anti-TNF-a antibodies significantly ( p  < 0.02) neu- 
tralized the TNF activity in the test fluid, whereas anti- 
TNF-/3 antibodies only marginally inhibited the TNF ac- 
tivity. A combination of anti-TNF-a and -p almost com- 
pletely ( p  < 0.001) inhibited the TNF activity. This sug- 
gests that LPS-induced TNF in our culture may be pri- 
marily produced by monocytes. 
To examine the specificity of alcohol-induced suppres- 
sion of TNF production, experiments were performed to 
assess the effect of acetaldehyde, a primary metabolite of 
alcohol on TNF production by normal blood. Data pre- 
sented in Fig. 4 show that acetaldehyde at 0.001, 0.002, 
and 0.003% concentrations similar to in vivo 
 concentration^^'.^^ did not inhibit LPS induced TNF pro- 
duction by normal blood. There was no significant con- 
centration effect [F(3,12) = 0.47, p > 0.101, nor was the 
linear contrast significant [F(  1,12) = 0.74, p > 0.101. 
DISCUSSION 
Previous studies have shown that alcohol consumption 
is associated with abnormalities of hum~ral”-’~ and cel- 
lular i m m ~ n i t y , ~ ~ - ~ ~  including dysfunctions of suppres- 
s0r,24-27 helper,28 and cytotoxic lymphocyte a ~ t i v i t i e s , ~ ~ - ~ ~  
and production of various soluble immune rnediator~.~~ 
Rats fed with diet containing EtOH also indicated a loss 
in cells from the thymus and lymph nodes, and showed 
reduced proliferative response to concanavalin 
whereas their ability to produce IL-2 and the numbers of 
IL-2 receptors were not affected.22 The effects of alcohol 
on the production and release of various cytokines by 
effector cells and on the functions of various effector cells 
responding to various stimuli have not been clearly eluci- 
dated. Previous studies have shown that acute EtOH in- 
toxication in rats markedly suppressed serum and lung 
TNF elicited in response to LPS, as well as suppressed 
neutrophil recruitment in the alveoli of rats.37 Recent 
studies have shown that acute alcohol administration 
markedly reduced S. aureus- or K. pneumoniae-induced 
TNF activity in lung lavage fluids of rats.38 DSouza et 
al.43 have shown that acute EtOH administration de- 
creased the circulating serum TNF levels in rats. Admin- 
istration of rTNF has been shown to enhance the bacteri- 
cidal capacity of the lung against S. aure~is,4~ suggesting 
that TNF plays an important role against infection. Acute 
alcohol intoxication of rats also showed an alteration of 
TNF-a receptors on ne~trophi ls .~~ In the murine model, 
dietary alcohol did not significantly affect in vitro TNF 
production, whereas splenocytes from mice fed either 
EtOH or control diet produced significantly lower levels 
of mitogen-induced TNF production when cultured with 
EtOH.46 EtOH also downregulated TNF-a production of 
the in vivo-preactivated monocytes of trauma patients.47 
The results presented in the present study show that 
alcohol at intoxicating levels in vivo added directly to the 
normal human whole blood and separated total mono- 
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Table 1. Effect of EtOH on LPS-Induced TNF Production by Normal Blood 
EtOH concentrations ( O h  v/v) 
No. of 
monocyte/ml 
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( p  c 0.01) 
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( p  c 0.001) 
One ml aliquots of whole blood samples were cultured with 10 pg/ml of LPS with or without different concentrations of EtOH for 4 hr at 37OC. Plasma samples were 
assayed for TNF levels using a TNF-sensitive WEHl 164 subclone 13 cell line. A total of 15 different blood samples were studied, and the values of TNF were expressed 
as mean i SO. 
Table 2. Effect of EtOH on TNF Production by Total Mononuclear Cells 
EtOH concentrations (YO v/v) 
[TNF (ng/ml)l 
Experiment 
no. 0 0.1 0.2 0.3 
1 194.4 177.7 173.2 140.2 
2 231 .O 176.8 163.7 156.2 
3 222.5 193.6 164.0 156.1 
4 216.6 199.0 152.1 158.2 
Mean f SD 216.6 f 14.7 186.8 f 11.2 163.3 f 8.6 152.7 f 8.4 
Peripheral blood mononuclear cells (1 x 10' cells/ml) were cultured for 4 hr with 
10 pg/ml of LPS with or without EtOH. Culture supernatants were examined for 
TNF using WEHl cell assay. TNF levels in culture supernatants produced without 
LPS manifested negligible levels of TNF (data not shown). 
Table 3. Inhibition of TNF Activity by Anti-TNF Antibodies 
Treatment of LPS-induced 
TNF supernatant TNF (ng/ml) YO inhibition 
None 192.8 f 14.9 - 
Anti-TNF-a (1:80 dilution) 50.3 f 7.6 ( p  c 0.02) 73.9 
Anti-TNF-B (1330 dilution) 165.5 f 15.6 ( p  c 0.3) 14.1 
Anti-TNF-a + -p 15.2 f 2.9 ( p  < 0.001) 92.1 
Culture supernatants from LPS-stimulated peripheral blood mononuclear cell 
cultures were incubated with either anti-TNF-a or -p or TNF-a + -p (1:80 dilutions 
previously determined to yield maximum TNF inhibition) for 1 hr at 37OC and then 
assayed for TNF using WEHl cell assay. Data represent the mean f SO of TNF 
levels from three experiments performed in triplicate determinations. Statistical 
significances of the differences between untreated and treated samples were 
evaluated by Student's t test. 
nuclear cells significantly suppressed the LPS-induced 
TNF production. Blood cultured with different concentra- 
tions of EtOH or acetaldehyde without LPS did not induce 
the production of TNF (data not shown). 
Previous studies have shown that TNF is produced by 
different subsets of circulating T-cells', 5 ,6  and macro- 
TNF can also influence the functions of dif- 
ferent cells, including T, B, polymorphonuclear, NK, 
LAK, and macro phage^.^-'^ Alcohol is known to affect a 
variety of immunological responses of circulating mono- 










CII) s 75 
LL 





0 0.001 0.002 0.003 
Acetaldehyde concentrations (%) 
Fig. 4. Effect of acetaldehyde on LPSinduced TNF production by normal blood. 
Aliquots of whole blood samples were cultured with 10 pg/ml of LPS and different 
concentrations of acetaldehyde for 4 hr at 37OC. Plasma samples were assayed 
for TNF levels using a TNF-sensitive WEHl 164 subclone 13 cell line. A total of five 
separate experiments using five different blood samples were studied, and values 
were expressed as mean f SO. Statistical significance of the differences between 
the control and acetaldehyde-treated samples were evaluated by two-tailed Stu- 
dent's t test. Mean monocyte count in these blood samples was 673 f 93 (so)/ml 
of blood. 
noregulatory molecule and alcohol is known to affect 
various functions of circulating effector cells, studies on 
the effect of alcohol on TNF production by circulating 
monocytes/macrophages or T-cells may be of significance 
in understanding the pathogenesis of alcohol-associated 
immune dysfunctions in clinical situations. 
Our experiments using whole blood and separated total 
mononuclear cells produced similar results, although sep- 
arated mononuclear cells produced slightly higher levels 
of TNF (2 16 vs. 182 in tables 2 and 1, respectively). It is 
possible that the ex vivo model system using whole blood 
as originally described39 may, therefore, be a good model 
system very similar to in vivo. This system potentially 
eliminates the artifacts due to adherence phenomenon48 
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and also reduces the LPS contamination, because minimal 
handling of the specimen is required. This system may 
reduce the confounding variables resulting from isolating 
cellular subsets for the preparation of TNF. Because cel- 
lular interactions are known to influence cytokine pro- 
d u c t i o n ~ , ~ ~ , ~ ~  the use of whole blood may preserve the 
cellular integrity. Further, the use of whole blood may also 
preserve the LPS binding protein facilitating the maxi- 
mum cellular response to LPS in the assay system. Al- 
though the whole blood system may be a limited lymphoid 
system in comparison with the intact animal and cannot 
accurately mimic the highly complex in vivo system or 
intact animals, it is possible that this system has consid- 
erable relevance to in vivo situations. Although alcohol 
levels in tissue and cell membranes may vary, a concen- 
tration of 0.3-0.4% in blood results in severe intoxication, 
whereas 0.5% leads to coma. Chronic alcoholics may 
manifest greater suppressive effects of alcohol on TNF 
production, because increased levels of alcohol are main- 
tained over longer periods of chronic drinking. It is inter- 
esting to note that alcohol as low as 0.1 % could signifi- 
cantly inhibit TNF production by whole blood, whereas 
alcohol at a similar concentration (0.1 %) did not manifest 
any significant effect on TNF production by the separated 
total mononuclear cells; rather, high concentrations of 
alcohol (0.2 and 0.3%) were required to mediate a signif- 
icant inhibition. Our recent studies showed an increase in 
the number of cells bearing IL-2 R and I2 markers in 
alcoholic patients compared with that of matched con- 
t r o l ~ . ~ ~  The effects of EtOH on the production of TNF by 
lymphocyte or monocyte subpopulations responding to 
various specific and nonspecific stimuli in addition to LPS 
and the number or affinity or avidity of TNF binding 
receptors present on various subpopulations subjected to 
isolation procedures in comparison to whole blood needs 
to be investigated. Our studies using the whole blood 
samples indicated a significant correlation between TNF 
production and number of monocytes (Fig. 3). It is im- 
portant to note that alcohol at 0.1 % and 0.2% in culture 
condition levels or similar to those found in humans under 
varying degrees of intoxication levels significantly sup- 
pressed TNF, a potent mediator of inflammatory cascade 
and an important immunoregulatory substance against 
various infections. Furthermore, the fact that acetalde- 
hyde, an active metabolite of alcohol, did not produce 
similar TNF suppression, points to the specificity of this 
reaction. In summary, our data show that alcohol at 
intoxicating levels produces suppression of LPS-induced 
TNF production by whole blood, as well as separated total 
mononuclear cells. Results of these studies are consistent 
with that of other in vivo  finding^^',^^'^^ and present direct 
evidence that one of the mechanisms of alcohol-mediated 
immunosuppression may be associated with decreased 
production of TNF. This finding may explain the noted 
increase in susceptibility to infection reported in alcoholic 
patients. 
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